Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Besarab A., Bolton W. K., Browne J. K., Egrie J. C., Nissenson A. R., Okamoto D. M., Schwab S. J., Goodkin D. A. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998 Aug 27;339(9):584–590. doi: 10.1056/NEJM199808273390903. [DOI] [PubMed] [Google Scholar]
- Mancini Donna M., Katz Stuart D., Lang Chim C., LaManca John, Hudaihed Alhakam, Androne Ana-Silvia. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003 Jan 21;107(2):294–299. doi: 10.1161/01.cir.0000044914.42696.6a. [DOI] [PubMed] [Google Scholar]
- Silverberg D. S., Wexler D., Blum M., Keren G., Sheps D., Leibovitch E., Brosh D., Laniado S., Schwartz D., Yachnin T. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000 Jun;35(7):1737–1744. doi: 10.1016/s0735-1097(00)00613-6. [DOI] [PubMed] [Google Scholar]
- Silverberg D. S., Wexler D., Sheps D., Blum M., Keren G., Baruch R., Schwartz D., Yachnin T., Steinbruch S., Shapira I. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001 Jun 1;37(7):1775–1780. doi: 10.1016/s0735-1097(01)01248-7. [DOI] [PubMed] [Google Scholar]
- Smith Kyle J., Bleyer Anthony J., Little William C., Sane David C. The cardiovascular effects of erythropoietin. Cardiovasc Res. 2003 Sep 1;59(3):538–548. doi: 10.1016/s0008-6363(03)00468-1. [DOI] [PubMed] [Google Scholar]